Akkure
Akkure Genomics is an AI-powered digital health company specializing in precision oncology and clinical trial recruitment. They leverage AI and genomics to match patients with suitable cancer trials, moving beyond traditional eligibility criteria to focus on a patient's unique genetic profile. Their solutions cater to various stakeholders, including charities, pharmacies, primary care centers, and hospitals, aiming to streamline trial recruitment, improve patient outcomes, and advance cancer research. Akkure Genomics partners with organizations like Microsoft AI to enhance their platform capabilities, such as the 'Clinical Trial Matcher,' which aids in finding relevant trials for patients and cohorts for trials. They are committed to data privacy (GDPR/HIPAA compliant) and patient-centricity, enabling patients to control and own their medical data.
Akkure
Akkure Genomics is an AI-powered digital health company specializing in precision oncology and clinical trial recruitment. They leverage AI and genomics to match patients with suitable cancer trials, moving beyond traditional eligibility criteria to focus on a patient's unique genetic profile. Their solutions cater to various stakeholders, including charities, pharmacies, primary care centers, and hospitals, aiming to streamline trial recruitment, improve patient outcomes, and advance cancer research. Akkure Genomics partners with organizations like Microsoft AI to enhance their platform capabilities, such as the 'Clinical Trial Matcher,' which aids in finding relevant trials for patients and cohorts for trials. They are committed to data privacy (GDPR/HIPAA compliant) and patient-centricity, enabling patients to control and own their medical data.
TL;DR
Sector: AI-powered digital health / precision oncology
Headquarters: Dublin, Ireland
Founded: 2019
Flagship product: Clinical Trial Matcher / Cancer Trials Finder
Data compliance: GDPR and HIPAA compliant
Company Overview
Problem Domain
Low clinical trial recruitment rates and mismatches between patients and trial eligibility; need for genomics-driven precision oncology tools.
Founded
2019
Industry
Digital health / Genomics / Precision oncology
Funding Track Record
€615,000
Crowdfunding campaign exceeded target early in the campaign
Recorded as a non-equity assistance event with PharmStars listed as lead
Received project and grant support including Disruptive Technology Innovation Fund and Enterprise Ireland
Investor Signal
“PharmStars and Spark Crowdfunding listed as investors”